天目药业
(600671)
| 流通市值：23.16亿 | | | 总市值：23.17亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 103,597,373.91 | 52,293,464.92 | 217,295,933.69 | 124,680,446.71 |
| 营业收入 | 103,597,373.91 | 52,293,464.92 | 217,295,933.69 | 124,680,446.71 |
| 二、营业总成本 | 100,327,240.73 | 49,169,104.63 | 188,884,737.6 | 129,724,584.88 |
| 营业成本 | 59,951,092.44 | 30,883,717.3 | 114,341,630.46 | 71,362,825.86 |
| 税金及附加 | 1,109,218.65 | 541,505.5 | 1,904,009.69 | 973,931.35 |
| 销售费用 | 6,399,486.78 | 2,303,031.06 | 8,229,385.95 | 4,464,595.57 |
| 管理费用 | 29,653,362.27 | 14,139,528.62 | 58,005,802.1 | 47,406,264.16 |
| 研发费用 | - | - | 1,206,796.12 | 106,796.12 |
| 财务费用 | 3,214,080.59 | 1,301,322.15 | 5,197,113.28 | 5,410,171.82 |
| 其中:利息费用 | 3,257,961.5 | 1,324,382.84 | 5,560,910.1 | 5,298,591.54 |
| 其中:利息收入 | 59,278.96 | 31,187.78 | 454,255.27 | 351,201.62 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 3,993.35 | - | 28,842.06 | 28,842.06 |
| 资产处置收益 | -614,970.43 | - | 12,684.84 | -137,260.06 |
| 资产减值损失(新) | -494,501.47 | 279,255.79 | -2,470,893.55 | 115,516.33 |
| 信用减值损失(新) | 293,545.27 | -270,579.72 | -1,469,149.84 | -2,643,053.74 |
| 其他收益 | 190,492.83 | 82,266.69 | 600,538.97 | 374,534.39 |
| 四、营业利润 | 2,648,692.73 | 3,215,303.05 | 25,113,218.57 | -7,305,559.19 |
| 加:营业外收入 | 4,619,205.46 | 1,454,628.78 | 8,790,650.76 | 4,931,772.57 |
| 减:营业外支出 | 149,157.34 | 99,412.33 | 4,831,673.54 | 1,254,008.67 |
| 五、利润总额 | 7,118,740.85 | 4,570,519.5 | 29,072,195.79 | -3,627,795.29 |
| 减:所得税费用 | 720,910.42 | 1,659,756.6 | 7,207,141.02 | 133,270.88 |
| 六、净利润 | 6,397,830.43 | 2,910,762.9 | 21,865,054.77 | -3,761,066.17 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 6,397,830.43 | 2,910,762.9 | 21,865,054.77 | -3,761,066.17 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 10,247,808.74 | 5,094,308.04 | 15,245,827.73 | -3,695,546.06 |
| 少数股东损益 | -3,849,978.31 | -2,183,545.14 | 6,619,227.04 | -65,520.11 |
| 扣除非经常损益后的净利润 | 5,903,269.48 | 3,657,507.82 | 9,963,922.75 | -7,864,460.4 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.04 | 0.13 | -0.03 |
| (二)稀释每股收益 | 0.08 | 0.04 | 0.13 | -0.03 |
| 九、综合收益总额 | 6,397,830.43 | 2,910,762.9 | 21,865,054.77 | -3,761,066.17 |
| 归属于母公司股东的综合收益总额 | 10,247,808.74 | 5,094,308.04 | 15,245,827.73 | -3,695,546.06 |
| 归属于少数股东的综合收益总额 | -3,849,978.31 | -2,183,545.14 | 6,619,227.04 | -65,520.11 |
| 公告日期 | 2025-08-28 | 2025-04-28 | 2025-04-01 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |